Department of Policy, Populations and Systems, School of Nursing, The George Washington University, Washington, DC, USA.
Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, USA.
Ethn Health. 2023 May;28(4):586-600. doi: 10.1080/13557858.2022.2116630. Epub 2022 Aug 31.
Human papillomavirus (HPV) is a common virus that currently infects nearly 80 million people in the United States (U.S.) and can lead to cancer. HPV vaccination provides safe, effective, and lasting protection against HPV infections. Nevertheless, vaccination rates remain suboptimal. The purpose of this study was to examine the relationship between sociodemographic characteristics, HPV and HPV vaccine awareness, and knowledge of HPV-associated cancers among U.S. adults.
Using responses from 3504 U.S. adults (aged 18 years and older) from the Health Information National Trends Survey 5 Cycle 2 (January-May 2018), we performed descriptive analysis to assess the level of awareness of HPV and HPV vaccines and knowledge of HPV-associated cancer. Multivariable regression analysis (including race, gender, age, level of education, marital status, number of children younger than 18) was conducted with weighted analysis.
About 62% of respondents had heard of HPV and HPV vaccine. Asians had a lower level of awareness than non-Hispanic Whites of HPV (36.4% vs. 66.1%) and HPV vaccine (48.7% vs. 67.1%). Multivariable analysis showed that race/ethnicity was associated with outcomes, with Asians being less likely to have heard about HPV (aOR = 0.17, 95% CI: 0.07-0.38) and non-Hispanic Blacks (aOR = 0.57, 95% CI: 0.35-0.91) and Hispanics (aOR = 0.54, 95% CI: 0.36-0.80) being less likely to have heard of the HPV vaccine than non-Hispanic Whites. In addition, gender, age, marital status, and education were associated with awareness of HPV and the HPV vaccine; in particular, individuals who were female, younger (18-45), married, and more highly educated were more likely to have heard of HPV and HPV vaccine.
Results highlight disparities in HPV and HPV vaccine awareness among racial/ethnic minority populations. Future interventions and legislation should target racial/ethnic minority populations to foster improvements in HPV vaccine uptake and reduce disparities in HPV-associated cancers.
人乳头瘤病毒（HPV）是一种常见病毒，目前感染了美国近 8000 万人，并可导致癌症。HPV 疫苗接种可提供针对 HPV 感染的安全、有效和持久保护。然而，疫苗接种率仍然不理想。本研究旨在研究美国成年人的社会人口统计学特征、HPV 和 HPV 疫苗意识以及 HPV 相关癌症知识之间的关系。
使用来自美国健康信息国家趋势调查 5 期 2 循环（2018 年 1 月至 5 月）的 3504 名美国成年人（年龄在 18 岁及以上）的回答，我们进行了描述性分析，以评估 HPV 和 HPV 疫苗的意识水平以及对 HPV 相关癌症的了解。使用加权分析进行多变量回归分析（包括种族、性别、年龄、教育程度、婚姻状况、18 岁以下儿童人数）。
约 62%的受访者听说过 HPV 和 HPV 疫苗。亚洲人的 HPV（36.4%比 66.1%）和 HPV 疫苗（48.7%比 67.1%）意识低于非西班牙裔白人。多变量分析表明，种族/民族与结果有关，亚洲人不太可能听说过 HPV（优势比[aOR] = 0.17，95%置信区间：0.07-0.38），非西班牙裔黑人（aOR = 0.57，95%置信区间：0.35-0.91）和西班牙裔（aOR = 0.54，95%置信区间：0.36-0.80）比非西班牙裔白人不太可能听说过 HPV 疫苗。此外，性别、年龄、婚姻状况和教育程度与 HPV 和 HPV 疫苗的认知有关；特别是女性、年轻（18-45 岁）、已婚和受教育程度较高的个体更有可能听说过 HPV 和 HPV 疫苗。
结果突出了少数族裔人群中 HPV 和 HPV 疫苗认知的差异。未来的干预措施和立法应针对少数族裔人群，以促进 HPV 疫苗接种率的提高，并减少 HPV 相关癌症的差异。
